APOE and Alzheimer disease: Recently, certain molecular regulators of microglial proliferation have been directly demonstrated to exist including triggering receptors expressed on myeloid cells 2 (TREM2) and apolipoprotein E (APOE) which are both among AD risk factors for late‐onset AD (LOAD).42